阵发性心房颤动导管消融术后早期复发的电生理机制和再消融

来源 :中国介入心脏病学杂志 | 被引量 : 0次 | 上传用户:wslin001
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的评价阵发性心房颤动(房颤)导管消融术后早期复发的电生理机制及早期再消融的可行性、疗效。方法入选环肺静脉电隔离术后1个月内复发的阵发性房颤患者14例,其中男8例,女6例,平均年龄61.8±8.4岁,房颤复发距首次消融时间4.9±3.7 d。若肺静脉传导恢复,则补点消融再次隔离。肺静脉隔离后诱发房颤,标测并消融非肺静脉异位灶。术后随访心电图和24 h动态心电图。结果14例患者首次消融后24.7±5.5 d再次消融。仅1例肺静脉传导无恢复,其余13例(92.9%)中均有至少一侧肺静脉传导恢复,补点消融后均再次隔离。3例(21.4%)为上腔静脉起源房颤,行上腔静脉隔离房颤终止。1例(7.1%)为界嵴上部起源,行局灶消融成功。3例诱发出典型心房扑动(房扑),1例诱发出左心房房扑,消融均成功。术后平均随访5.8±1.4个月,13例患者无房性快速性心律失常复发(不用抗心律失常药物),1例有阵发性房速发作(服用维拉帕米)。结论肺静脉传导恢复是阵发性房颤消融术后早期复发的主要因素,其次是非肺静脉(上腔静脉、界嵴)的异位灶,早期再消融可行有效。 Objective To evaluate the electrophysiological mechanism of early recurrence after paroxysmal atrial fibrillation (AF) catheter ablation and the feasibility and curative effect of early reablation. Methods Fourteen patients with paroxysmal atrial fibrillation who recurred within 1 month after pulmonary vein isolation were enrolled, including 8 males and 6 females, with an average age of 61.8 ± 8.4 years. The recurrence of atrial fibrillation was 4.9 ± 3.7 days . If the pulmonary venous conduction recovery, the point of ablation again isolated. Atrial fibrillation induced by pulmonary vein isolation, mapping and ablation of non-pulmonary venous heterotopic foci. After follow-up electrocardiogram and 24 h Holter. Results 14 patients reabsorbed again 24.7 ± 5.5 days after the first ablation. Only one case of pulmonary vein conduction without recovery, and the remaining 13 cases (92.9%) in at least one side of the pulmonary vein conduction recovery, after filling point ablation are again isolated. Three cases (21.4%) of the origin of atrial fibrillation in the superior vena cava, the superior vena cava isolated atrial fibrillation termination. One case (7.1%) was the origin of the upper crista and the ablation was successful. 3 cases induced typical atrial flutter (atrial flutter), 1 case induced left atrial flutter, ablation were successful. The patients were followed up for an average of 5.8 ± 1.4 months. Thirteen patients had atrial tachyarrhythmia recurrence (without antiarrhythmic drugs) and one had paroxysmal atrial tachycardia (taking verapamil). Conclusions Pulmonary venous conduction recovery is the main factor of early recurrence after paroxysmal atrial fibrillation ablation, followed by ectopic foci of non-pulmonary veins (superior vena cava and border cristae). Early reablation is feasible and effective.
其他文献
目的:观察强心合剂2号干预舒张性心力衰竭(DHF)患者的临床疗效及安全性,研究该药对DHF患者血浆中脑钠肽(BNP)含量的影响,探讨DHF的发病机制和强心合剂2号的作用机理.方法:选
目的 探讨鼻整形术中鼻尖上旋畸形的安全有效矫正方法.方法 11例原发性鼻尖上旋畸形及5例继发性鼻尖上旋畸形均采用自体耳软骨移植或与多孔高密度聚乙烯(Medpor)置入相结合的
目的 观察在不稳定型心绞痛中应用替罗非班的疗效.方法300例不稳定型心绞痛患者随机分成2组,标准肝素组给予不稳定型心绞痛标准肝素治疗,替罗非班组在不稳定型心绞痛标准肝素
目的 了解临床分离表皮葡萄球菌中耐甲氧西林菌株(MRSE)发生率及其耐药情况.方法 对128株表皮葡萄球菌进行头孢西丁纸片扩散法检测耐甲氧西林株,琼脂稀释法进行药敏试验.结果
目的 探讨输液泵推注20%甘露醇在小儿病毒性脑炎中对药物作用的影响以及对血管损伤的影响.方法 选取病例分为3组.A组107例,人工推注组;B组32例,静脉滴注组;C组222例,输液泵推
本文介绍了新诊断多发性骨髓瘤(MM)的治疗方案:干细胞移植候选者和非干细胞移植候选者初始治疗的选择;介绍了正在进行临床试验的新药。本文认为,新药治疗,尤其与标准方案联合治疗
随着医学诊断水平的提高和人口的老龄化,多发性骨髓瘤(MM)的发病率也逐年提高.当前MM仍被认为是一种不可治愈的疾病,因此,努力提高诊断水平,认真地研究合理的治疗方法,特别是
目的了解本院近10年来新生儿败血症病原菌及其耐药性变迁,以指导临床用药。方法对1997年3月至2002年3月收治的新生儿败血症(第1组)血培养检出菌、药敏试验结果进行回顾性调查
薛佰寿老先生善治热证,现举其应用四妙勇安汤治疗急性风湿热、扁桃体炎,口腔溃疡,带状疱疹等疾病,临床疗效显著,体现了中医异病同治之思想.
种植体周围炎是一种慢性进展性边缘性炎症,常导致种植体周围支撑骨组织的吸收,致使种植失败.它是一种病因、微生物学、组织病理学、临床表现及预后方面都与牙周炎极其相似的